Performance of Antigen Detection Tests for SARS-CoV-2: A Systematic Review and Meta-Analysis

Coronavirus disease 2019 (COVID-19) initiated global health care challenges such as the necessity for new diagnostic tests. Diagnosis by real-time PCR remains the gold-standard method, yet economical and technical issues prohibit its use in points of care (POC) or for repetitive tests in populations...

Full description

Saved in:
Bibliographic Details
Published in:Diagnostics (Basel) 2022-06, Vol.12 (6), p.1388
Main Authors: Tapari, Anastasia, Braliou, Georgia G., Papaefthimiou, Maria, Mavriki, Helen, Kontou, Panagiota I., Nikolopoulos, Georgios K., Bagos, Pantelis G.
Format: Article
Language:English
Subjects:
Accuracy
antigen test
Antigens
Asymptomatic
Bias
Coronaviruses
COVID-19
COVID-19 vaccines
diagnostic performance
Immunoassay
Infections
Medical laboratories
Meta-analysis
Methods
Public health
SARS-CoV-2
sensitivity
Severe acute respiratory syndrome coronavirus 2
Systematic Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Coronavirus disease 2019 (COVID-19) initiated global health care challenges such as the necessity for new diagnostic tests. Diagnosis by real-time PCR remains the gold-standard method, yet economical and technical issues prohibit its use in points of care (POC) or for repetitive tests in populations. A lot of effort has been exerted in developing, using, and validating antigen-based tests (ATs). Since individual studies focus on few methodological aspects of ATs, a comparison of different tests is needed. Herein, we perform a systematic review and meta-analysis of data from articles in PubMed, medRxiv and bioRxiv. The bivariate method for meta-analysis of diagnostic tests pooling sensitivities and specificities was used. Most of the AT types for SARS-CoV-2 were lateral flow immunoassays (LFIA), fluorescence immunoassays (FIA), and chemiluminescence enzyme immunoassays (CLEIA). We identified 235 articles containing data from 220,049 individuals. All ATs using nasopharyngeal samples show better performance than those with throat saliva (72% compared to 40%). Moreover, the rapid methods LFIA and FIA show about 10% lower sensitivity compared to the laboratory-based CLEIA method (72% compared to 82%). In addition, rapid ATs show higher sensitivity in symptomatic patients compared to asymptomatic patients, suggesting that viral load is a crucial parameter for ATs performed in POCs. Finally, all methods perform with very high specificity, reaching around 99%. LFIA tests, though with moderate sensitivity, appear as the most attractive method for use in POCs and for performing seroprevalence studies.
ISSN:2075-4418
2075-4418
DOI:10.3390/diagnostics12061388